Lushang Health Industry Development Co.,Ltd. Logo

Lushang Health Industry Development Co.,Ltd.

600223.SS

(1.2)
Stock Price

6,84 CNY

3.99% ROA

5.97% ROE

34.24x PER

Market Cap.

8.224.051.300,00 CNY

14.3% DER

1.24% Yield

6.01% NPM

Lushang Health Industry Development Co.,Ltd. Stock Analysis

Lushang Health Industry Development Co.,Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Lushang Health Industry Development Co.,Ltd. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE falls within an average range (3.04%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

2 ROA

The stock's ROA (1.11%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

3 PBV

The stock's PBV ratio (2.53x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

4 DER

The stock maintains a fair debt to equity ratio (88%), indicating a reasonable balance between the money it owes and the ownership it possesses.

5 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (440) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Lushang Health Industry Development Co.,Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Lushang Health Industry Development Co.,Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Lushang Health Industry Development Co.,Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Lushang Health Industry Development Co.,Ltd. Revenue
Year Revenue Growth
1996 139.158.457
1997 214.163.696 35.02%
1998 277.532.718 22.83%
1999 569.293.471 51.25%
2000 761.963.023 25.29%
2001 1.002.739.562 24.01%
2002 1.132.521.972 11.46%
2003 2.119.506.730 46.57%
2004 2.451.380.118 13.54%
2005 2.170.304.149 -12.95%
2006 1.239.377.060 -75.11%
2007 1.297.244.595 4.46%
2008 2.610.648.391 50.31%
2009 2.500.147.080 -4.42%
2010 3.018.402.426 17.17%
2011 2.381.698.574 -26.73%
2012 3.673.819.067 35.17%
2013 5.293.036.561 30.59%
2014 5.681.863.161 6.84%
2015 5.864.434.715 3.11%
2016 7.645.921.649 23.3%
2017 7.548.771.288 -1.29%
2018 8.821.312.533 14.43%
2019 10.289.206.911 14.27%
2020 13.615.482.089 24.43%
2021 12.363.270.871 -10.13%
2022 12.951.443.198 4.54%
2023 3.686.340.631 -251.34%
2023 4.542.327.946 18.84%
2024 4.097.690.048 -10.85%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Lushang Health Industry Development Co.,Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 24.169.177 100%
2018 30.132.732 19.79%
2019 46.067.256 34.59%
2020 77.166.218 40.3%
2021 118.752.087 35.02%
2022 133.916.665 11.32%
2023 142.807.824 6.23%
2023 140.858.092 -1.38%
2024 116.289.440 -21.13%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Lushang Health Industry Development Co.,Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 3.385.883
1997 3.608.056 6.16%
1998 3.453.997 -4.46%
1999 13.815.904 75%
2000 17.231.905 19.82%
2001 12.351.272 -39.52%
2002 21.947.544 43.72%
2003 26.434.884 16.98%
2004 35.234.825 24.98%
2005 79.754.185 55.82%
2006 170.873.493 53.33%
2007 74.540.124 -129.24%
2008 178.231.919 58.18%
2009 37.590.490 -374.14%
2010 18.530.774 -102.85%
2011 16.547.049 -11.99%
2012 38.164.030 56.64%
2013 45.432.892 16%
2014 46.507.798 2.31%
2015 42.078.669 -10.53%
2016 44.248.625 4.9%
2017 46.257.843 4.34%
2018 76.193.789 39.29%
2019 84.119.260 9.42%
2020 81.869.064 -2.75%
2021 107.947.505 24.16%
2022 93.308.846 -15.69%
2023 536.572.384 82.61%
2023 58.677.031 -814.45%
2024 -68.058.482 186.22%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Lushang Health Industry Development Co.,Ltd. EBITDA
Year EBITDA Growth
1996 17.240.622
1997 35.806.135 51.85%
1998 65.013.424 44.93%
1999 202.692.682 67.93%
2000 262.030.381 22.65%
2001 276.113.440 5.1%
2002 263.527.745 -4.78%
2003 345.099.703 23.64%
2004 280.629.908 -22.97%
2005 187.892.095 -49.36%
2006 -419.777.044 144.76%
2007 531.432.993 178.99%
2008 414.701.962 -28.15%
2009 578.697.969 28.34%
2010 622.379.988 7.02%
2011 288.607.950 -115.65%
2012 509.932.139 43.4%
2013 618.589.543 17.57%
2014 437.355.734 -41.44%
2015 365.669.714 -19.6%
2016 297.525.755 -22.9%
2017 317.791.558 6.38%
2018 600.974.388 47.12%
2019 735.667.593 18.31%
2020 1.105.729.681 33.47%
2021 1.146.728.599 3.58%
2022 1.118.050.150 -2.57%
2023 261.576.135 -327.43%
2023 383.371.470 31.77%
2024 389.939.080 1.68%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Lushang Health Industry Development Co.,Ltd. Gross Profit
Year Gross Profit Growth
1996 23.054.998
1997 43.304.368 46.76%
1998 55.800.714 22.39%
1999 173.564.091 67.85%
2000 199.820.912 13.14%
2001 174.679.171 -14.39%
2002 178.381.249 2.08%
2003 236.568.748 24.6%
2004 171.565.028 -37.89%
2005 82.858.613 -107.06%
2006 -164.689.331 150.31%
2007 -53.527.024 -207.68%
2008 389.363.311 113.75%
2009 903.661.959 56.91%
2010 1.022.032.344 11.58%
2011 646.917.753 -57.98%
2012 1.099.606.278 41.17%
2013 1.493.393.877 26.37%
2014 1.269.811.565 -17.61%
2015 1.169.014.378 -8.62%
2016 1.116.936.423 -4.66%
2017 1.079.171.838 -3.5%
2018 1.787.701.622 39.63%
2019 2.167.635.996 17.53%
2020 2.768.387.083 21.7%
2021 3.176.025.924 12.83%
2022 3.192.277.260 0.51%
2023 2.024.090.020 -57.71%
2023 2.038.431.757 0.7%
2024 2.098.694.004 2.87%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Lushang Health Industry Development Co.,Ltd. Net Profit
Year Net Profit Growth
1996 26.563.802
1997 46.412.695 42.77%
1998 60.255.181 22.97%
1999 135.923.387 55.67%
2000 147.001.321 7.54%
2001 139.727.108 -5.21%
2002 102.223.946 -36.69%
2003 101.152.775 -1.06%
2004 21.525.194 -369.93%
2005 -121.067.421 117.78%
2006 -672.949.026 82.01%
2007 22.753.744 3057.53%
2008 -297.393.985 107.65%
2009 439.366.882 167.69%
2010 440.981.641 0.37%
2011 234.627.546 -87.95%
2012 246.602.027 4.86%
2013 264.026.432 6.6%
2014 206.420.706 -27.91%
2015 112.491.753 -83.5%
2016 92.372.107 -21.78%
2017 105.361.220 12.33%
2018 162.060.307 34.99%
2019 344.508.204 52.96%
2020 638.669.121 46.06%
2021 361.900.881 -76.48%
2022 65.098.400 -455.93%
2023 190.438.242 65.82%
2023 303.387.173 37.23%
2024 272.846.372 -11.19%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Lushang Health Industry Development Co.,Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 -1 100%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 1 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Lushang Health Industry Development Co.,Ltd. Free Cashflow
Year Free Cashflow Growth
1998 34.733.497
1999 -41.705.365 183.28%
2000 -536.889.619 92.23%
2001 53.391.051 1105.58%
2002 -103.496.220 151.59%
2003 -23.466.847 -341.03%
2004 -155.279.494 84.89%
2005 -110.781.247 -40.17%
2006 -55.619.810 -99.18%
2007 25.216.397 320.57%
2008 -564.178.202 104.47%
2009 44.993.450 1353.91%
2010 -1.472.081.305 103.06%
2011 -3.654.592.942 59.72%
2012 -88.987.893 -4006.84%
2013 -1.102.008.240 91.92%
2014 -2.368.202.071 53.47%
2015 -1.812.383.969 -30.67%
2016 -2.493.480.833 27.32%
2017 1.532.149.852 262.74%
2018 2.061.613.306 25.68%
2019 -3.367.385.263 161.22%
2020 4.290.951.983 178.48%
2021 6.566.696.006 34.66%
2022 831.980.469 -689.28%
2023 80.513.185 -933.35%
2023 325.473.748 75.26%
2024 143.710.337 -126.48%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Lushang Health Industry Development Co.,Ltd. Operating Cashflow
Year Operating Cashflow Growth
1998 42.426.492
1999 59.667.752 28.9%
2000 166.445.340 64.15%
2001 331.741.123 49.83%
2002 165.204.558 -100.81%
2003 340.097.867 51.42%
2004 337.653.001 -0.72%
2005 212.616.005 -58.81%
2006 -25.179.702 944.39%
2007 72.179.321 134.88%
2008 -509.316.018 114.17%
2009 48.387.638 1152.57%
2010 -1.464.829.519 103.3%
2011 -3.633.914.471 59.69%
2012 103.585.906 3608.12%
2013 -1.087.851.083 109.52%
2014 -2.363.097.628 53.97%
2015 -1.797.507.829 -31.47%
2016 -2.468.118.717 27.17%
2017 1.555.133.569 258.71%
2018 2.095.276.854 25.78%
2019 -3.307.182.481 163.36%
2020 4.448.018.883 174.35%
2021 6.848.228.115 35.05%
2022 998.095.209 -586.13%
2023 87.624.097 -1039.06%
2023 536.841.261 83.68%
2024 182.065.223 -194.86%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Lushang Health Industry Development Co.,Ltd. Capital Expenditure
Year Capital Expenditure Growth
1998 7.692.994
1999 101.373.117 92.41%
2000 703.334.959 85.59%
2001 278.350.071 -152.68%
2002 268.700.778 -3.59%
2003 363.564.714 26.09%
2004 492.932.495 26.24%
2005 323.397.252 -52.42%
2006 30.440.108 -962.41%
2007 46.962.924 35.18%
2008 54.862.184 14.4%
2009 3.394.188 -1516.36%
2010 7.251.785 53.2%
2011 20.678.471 64.93%
2012 192.573.799 89.26%
2013 14.157.157 -1260.26%
2014 5.104.443 -177.35%
2015 14.876.140 65.69%
2016 25.362.116 41.35%
2017 22.983.717 -10.35%
2018 33.663.547 31.73%
2019 60.202.782 44.08%
2020 157.066.900 61.67%
2021 281.532.109 44.21%
2022 166.114.740 -69.48%
2023 7.110.911 -2236.05%
2023 211.367.513 96.64%
2024 38.354.886 -451.08%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Lushang Health Industry Development Co.,Ltd. Equity
Year Equity Growth
1996 317.075.060
1997 363.487.755 12.77%
1998 738.107.879 50.75%
1999 1.602.992.131 53.95%
2000 1.658.077.921 3.32%
2001 1.807.935.501 8.29%
2002 1.762.340.042 -2.59%
2003 1.900.596.491 7.27%
2004 1.858.763.336 -2.25%
2005 1.723.856.727 -7.83%
2006 902.556.696 -91%
2007 681.961.835 -32.35%
2008 458.342.792 -48.79%
2009 692.953.865 33.86%
2010 1.150.533.542 39.77%
2011 1.403.236.448 18.01%
2012 1.731.584.833 18.96%
2013 2.024.295.752 14.46%
2014 2.252.295.424 10.12%
2015 2.410.778.800 6.57%
2016 2.549.380.040 5.44%
2017 2.620.646.625 2.72%
2018 2.888.861.144 9.28%
2019 4.695.648.156 38.48%
2020 6.517.411.081 27.95%
2021 6.499.789.705 -0.27%
2022 5.566.890.630 -16.76%
2023 4.680.141.093 -18.95%
2023 4.674.438.292 -0.12%
2024 4.734.181.221 1.26%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Lushang Health Industry Development Co.,Ltd. Assets
Year Assets Growth
1996 424.034.618
1997 466.862.635 9.17%
1998 887.204.322 47.38%
1999 1.771.660.345 49.92%
2000 2.170.017.127 18.36%
2001 2.531.082.903 14.27%
2002 2.902.055.948 12.78%
2003 3.994.024.829 27.34%
2004 4.199.200.660 4.89%
2005 4.589.693.479 8.51%
2006 4.223.559.734 -8.67%
2007 3.932.331.232 -7.41%
2008 4.805.409.978 18.17%
2009 7.235.845.056 33.59%
2010 11.137.811.533 35.03%
2011 17.634.377.861 36.84%
2012 21.558.537.421 18.2%
2013 27.298.931.080 21.03%
2014 30.817.631.617 11.42%
2015 34.760.903.817 11.34%
2016 42.525.357.657 18.26%
2017 43.394.898.932 2%
2018 48.878.339.967 11.22%
2019 56.019.444.901 12.75%
2020 61.498.584.742 8.91%
2021 61.415.459.283 -0.14%
2022 58.473.809.904 -5.03%
2023 7.817.827.107 -647.95%
2023 10.882.828.776 28.16%
2024 6.347.533.764 -71.45%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Lushang Health Industry Development Co.,Ltd. Liabilities
Year Liabilities Growth
1996 106.959.558
1997 103.374.880 -3.47%
1998 149.096.443 30.67%
1999 168.668.213 11.6%
2000 511.939.205 67.05%
2001 723.147.401 29.21%
2002 1.139.715.906 36.55%
2003 2.093.428.336 45.56%
2004 2.340.437.322 10.55%
2005 2.865.836.751 18.33%
2006 3.321.003.036 13.71%
2007 3.250.369.396 -2.17%
2008 4.347.067.184 25.23%
2009 6.542.891.190 33.56%
2010 9.987.277.990 34.49%
2011 16.231.141.412 38.47%
2012 19.826.952.588 18.14%
2013 25.274.635.327 21.55%
2014 28.565.336.192 11.52%
2015 32.350.125.016 11.7%
2016 39.975.977.616 19.08%
2017 40.774.252.307 1.96%
2018 45.989.478.823 11.34%
2019 51.323.796.743 10.39%
2020 54.981.173.661 6.65%
2021 54.915.669.576 -0.12%
2022 52.906.919.273 -3.8%
2023 3.082.507.346 -1616.36%
2023 6.208.390.484 50.35%
2024 1.561.579.396 -297.57%

Lushang Health Industry Development Co.,Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3.93
Net Income per Share
0.24
Price to Earning Ratio
34.24x
Price To Sales Ratio
2.06x
POCF Ratio
18.12
PFCF Ratio
25.18
Price to Book Ratio
2.04
EV to Sales
1.39
EV Over EBITDA
17.16
EV to Operating CashFlow
12.27
EV to FreeCashFlow
17.06
Earnings Yield
0.03
FreeCashFlow Yield
0.04
Market Cap
8,22 Bil.
Enterprise Value
5,57 Bil.
Graham Number
4.6
Graham NetNet
2.37

Income Statement Metrics

Net Income per Share
0.24
Income Quality
1.89
ROE
0.06
Return On Assets
0.04
Return On Capital Employed
0.05
Net Income per EBT
0.88
EBT Per Ebit
1.23
Ebit per Revenue
0.06
Effective Tax Rate
0.16

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.5
Operating Profit Margin
0.06
Pretax Profit Margin
0.07
Net Profit Margin
0.06

Dividends

Dividend Yield
0.01
Dividend Yield %
1.24
Payout Ratio
0.99
Dividend Per Share
0.1

Operating Metrics

Operating Cashflow per Share
0.45
Free CashFlow per Share
0.32
Capex to Operating CashFlow
0.28
Capex to Revenue
0.03
Capex to Depreciation
2.4
Return on Invested Capital
0.04
Return on Tangible Assets
0.04
Days Sales Outstanding
55.3
Days Payables Outstanding
84.98
Days of Inventory on Hand
99.14
Receivables Turnover
6.6
Payables Turnover
4.3
Inventory Turnover
3.68
Capex per Share
0.13

Balance Sheet

Cash per Share
3,19
Book Value per Share
4,71
Tangible Book Value per Share
4.38
Shareholders Equity per Share
3.97
Interest Debt per Share
0.6
Debt to Equity
0.14
Debt to Assets
0.09
Net Debt to EBITDA
-8.17
Current Ratio
3.02
Tangible Asset Value
4,45 Bil.
Net Current Asset Value
2,90 Bil.
Invested Capital
4548166503
Working Capital
2,99 Bil.
Intangibles to Total Assets
0.05
Average Receivables
0,67 Bil.
Average Payables
0,46 Bil.
Average Inventory
538553449
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Lushang Health Industry Development Co.,Ltd. Dividends
Year Dividends Growth
2001 0
2003 0 0%
2004 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2024 0 0%

Lushang Health Industry Development Co.,Ltd. Profile

About Lushang Health Industry Development Co.,Ltd.

Lushang Health Industry Development Co.,Ltd. develops and operates real estate properties in China. It develops residences, commercial complexes, shopping malls, high-end office buildings, star hotels, and other projects. The company was formerly known as Lushang Property Co., Ltd. and changed its name to Lushang Health Industry Development Co.,Ltd. in June 2019. Lushang Health Industry Development Co.,Ltd. is based in Jinan, China. Lushang Health Industry Development Co.,Ltd. is a subsidiary of Shandong Province Commercial Group Co., Ltd.

CEO
Mr. Baiqiang Xu
Employee
3.651
Address
Building 5
Jinan, 250014

Lushang Health Industry Development Co.,Ltd. Executives & BODs

Lushang Health Industry Development Co.,Ltd. Executives & BODs
# Name Age
1 Mr. Baiqiang Xu
Financial Director
70
2 Mr. Hongyang Zhang
Deputy GM & Secretary
70
3 Mr. Deqiang Zheng
Deputy General Manager
70
4 Ms. Xixi Dou
Deputy General Manager
70
5 Mr. Chunming Gao
Deputy General Manager
70
6 Mr. Hongtao Wang
Accounting Supervisor
70

Lushang Health Industry Development Co.,Ltd. Competitors